Editing Skin cancer (section)

== Prognosis ==
The mortality rate of basal-cell and squamous-cell carcinoma is around 0.3%, causing 2000 deaths per year in the US. In comparison, the mortality rate of melanoma is 15–20% and it causes 6500 deaths per year.<ref name=BoringCC>{{cite journal | vauthors = Boring CC, Squires TS, Tong T | title = Cancer statistics, 1991 | journal = CA | volume = 41 | issue = 1 | pages = 19–36 | year = 1991 | pmid = 1984806 | doi = 10.3322/canjclin.41.1.19 | s2cid = 40987916 | doi-access = free }}</ref>{{rp|29,31}} Even though it is much less common, malignant melanoma is responsible for 75% of all skin cancer-related deaths.<ref name=AAFP>{{cite journal | vauthors = Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ | title = Early detection and treatment of skin cancer | journal = American Family Physician | volume = 62 | issue = 2 | pages = 357–68, 375–6, 381–2 | date = July 2000 | pmid = 10929700 | url = http://www.aafp.org/afp/20000715/357.html | url-status = live | archive-url = https://web.archive.org/web/20080724153613/http://www.aafp.org/afp/20000715/357.html | archive-date = 24 July 2008 }}</ref>

The survival rate for people with melanoma depends upon when they start treatment. The cure rate is very high when melanoma is detected in early stages, when it can easily be removed surgically. The prognosis is less favorable if the melanoma has spread to other parts of the [[Human body|body]].<ref>{{cite web|url=http://www.skincancerjournal.com/melanoma/|title=Malignant Melanoma Cancer | work =  Skin Cancer Journal | date = 2009 |access-date=2010-07-02|url-status=live|archive-url=https://web.archive.org/web/20100323064318/http://www.skincancerjournal.com/melanoma/|archive-date=23 March 2010}}</ref> As of 2003 the overall five-year cure rate with Mohs' micrographic surgery was around 95 percent for recurrent basal cell carcinoma.<ref>{{cite journal | vauthors = Wong CS, Strange RC, Lear JT | title = Basal cell carcinoma | journal = BMJ | volume = 327 | issue = 7418 | pages = 794–798 | date = October 2003 | pmid = 14525881 | pmc = 214105 | doi = 10.1136/bmj.327.7418.794 }}</ref>

[[Australia]] and [[New Zealand]] exhibit one of the highest rates of skin cancer incidence in the world, almost four times the rates registered in the United States, the [[UK]] and [[Canada]]. Around 434,000 people receive treatment for non-melanoma skin cancers and 10,300 are treated for melanoma. Melanoma is the most common type of cancer in people between 15 and 44 years in both countries. The incidence of skin cancer has been increasing.<ref>{{cite web |url= http://www.cancer.org.au/cancersmartlifestyle/SunSmart/Skincancerfactsandfigures.htm |title=Skin Cancer Facts and Figures | date = 3 May 2012 | work = Cancer Council Australia |access-date=2013-12-01|quote=From 1982 to 2007 melanoma diagnoses increased by around 50%. From 1998 to 2007, GP consultations to treat non-melanoma skin cancer increased by 14%, to reach 950,000 visits each year.|url-status=live|archive-url=https://web.archive.org/web/20120810071104/http://www.cancer.org.au/cancersmartlifestyle/SunSmart/Skincancerfactsandfigures.htm|archive-date=10 August 2012}}</ref> The incidence of melanoma among [[Auckland]] residents of European descent in 1995 was 77.7 cases per 100,000 people per year, and was predicted to increase in the 21st century because of "the effect of local stratospheric ozone depletion and the time lag from sun exposure to melanoma development."<ref>{{cite journal | vauthors = Jones WO, Harman CR, Ng AK, Shaw JH | title = Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world | journal = World Journal of Surgery | volume = 23 | issue = 7 | pages = 732–735 | date = July 1999 | pmid = 10390596 | doi = 10.1007/pl00012378 | url = http://www.kmc.co.nz/ViewArticle.aspx?id=32744 | url-status = dead | s2cid = 11995057 | archive-url = https://web.archive.org/web/20131203031716/http://www.kmc.co.nz/ViewArticle.aspx?id=32744 | archive-date = 3 December 2013 }}</ref>